J9228 Ipilimumab - CanMED: HCPCS

Return Home

Home

SEER Data & Software

Observational Research in Oncology Toolbox

Medication Information

CanMED: HCPCS

Generic Name:

Ipilimumab

Brand Name:

Yervoy

Strength:

1mg

HCPCS:

J9228

SEER*Rx Category:

Immunotherapy

Major Drug Class:

Checkpoint Inhibitor

Minor Drug Class:

CTLA-4

Oral (Y/N):

No

FDA Approval Year:

2011

FDA Discontinuation Year:

CMS Effective Date:

Jan. 1, 2012

CMS Discontinuation Date:

Status:

In Use